[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-252976-105":53,"doc-detail-252976-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","hcv-elimination-in-the-us-department-of-veterans-affairs-overview-and-implementation-program","HCV Elimination in the US Department of Veterans Affairs - Overview and Implementation Program","","Since 2014, the US Department of Veterans Affairs has virtually eliminated hepatitis C virus (HCV) among Veterans receiving care by building a national program that combines provider and patient education, quality improvement, and continuous data dissemination. Earlier VA observations that Veterans had higher HCV prevalence drove a comprehensive strategy featuring evidence-based testing and treatment guidance, a national clinical case registry, and clinical leadership coordination. A field network of Hepatitis C Innovation Teams supported rapid care redesign after all-oral direct-acting antivirals became available in 2014.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/hcv-elimination-in-the-us-department-of-veterans-affairs-overview-and-implementation-program/252976/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/hcv-elimination-in-the-us-department-of-veterans-affairs-overview-and-implementation-program/252976.png","ImageObject",442,249,{"name":88,"@type":89},"Jake","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-19","2026-09-13",true,{"@type":98,"interactionType":99,"userInteractionCount":25},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What prompted the VA to launch a national HCV elimination program?","Question",{"text":108,"@type":109},"The VA identified that HCV was more prevalent among Veterans in VA care than in the general US population, which triggered a comprehensive program focused on education, quality improvement, and clinical tool deployment.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"What organizational infrastructure supported the VA’s rapid response in 2014?",{"text":113,"@type":109},"A robust HCV infrastructure, especially the national clinical case registry, enabled quick activation when all-oral direct-acting antivirals became available.",{"name":115,"@type":106,"acceptedAnswer":116},"What was the role of Hepatitis C Innovation Teams (HITs)?",{"text":117,"@type":109},"HITs were small, field-based units designed to rapidly redesign clinical systems and drive innovations, using shared quantitative access and quality goals while selecting projects suited to each region.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},252976,1791362193,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":25,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":140,"read_time":73},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","~~ ~~ review ~~ ~~  \nHCv elimination in the Us Department of veterans affairs  \nRachel Gonzalez, M. P. H.,*,\\# Angela Park, Pharm. D.,†,\\# Vera Yakovchenko, M. P. H.,‡ Shari Rogal, M. D., M. P. H.,§,¶  \nMaggie Chartier, Psy. D., M. P. H.,** Timothy R. Morgan, M. D.,††,‡‡,\\#\\# and David Ross, M. D., Ph. D., M. B. I. **,\\#\\#  \nSince 2014, the US Department of Veterans Affairs (VA), the largest single provider of care for chronic hepatitis C virus infection (HCV) in the United States, has virtually eliminated HCV among Veterans in VA care (Fig. 1) . The VA’s experience provides lessons learned to other healthcare organizations (HCOs) pursuing HCV elimination.  \nThe discovery two decades ago that HCV is three times more prevalent among Veterans in VA care than in the general US population 1,2 prompted the VA to launch a comprehensive national HCV program focused on provider and patient education, quality improvement, data dissemination, and clinical tool deployment (Table 1) .  \nAbbreviations: CCR, clinical case registry; DAA, direct-acting antiviral agent; ERIC, Expert Recommendations for Implementing Change; HCO, healthcare organization; HCV, hepatitis C virus; HIT, Hepatitis C Innovation Team; LT, leadership team; SME, subject matter expert; SVR, sustained viral response; VA, US Department of Veterans Affairs; VAMC, VA Medical Center; VISN, Veterans Integrated Service Network.  \nFrom the * Department of Veterans Affairs, Sierra Pacific Veterans Integrated Service Network, Pharmacy Benefits Management, Mather, CA; †Department of Veterans Affairs, Office of Healthcare Transformation, Washington, DC; ‡Center for Healthcare Organization and Implementation Research, Edith Norse Rogers Memorial VA Hospital, Bedford, MA; § Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA; ¶ Departments of Medicine and Surgery and Center for Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA; **Veterans Health Administration, HIV, Hepatitis, and Related Conditions Programs, Office of Specialty Care Services, Washington, DC; ††Gastroenterology Section, VALong Beach Healthcare System, Long Beach, CA; and ‡‡Department of Medicine, Division of Gastroenterology, University of California, Irvine, CA.  \n\\# Equal first authors.  \n\\#\\# Equal senior authors.  \nFor more information, please visit: Hepatitis C Overview-Viral Hepatitis and Liver Disease ([va.gov](va.gov)) .  \nSR’s time was funded by NIDA K23 DA048182 and this work was partially funded by QUERI PEC 19-307 and HHRC. Potential conflict of interest: Timothy Morgan participated in hepatitis C clinical trials funded by AbbVie, Gilead, Merck, and Hoffman-LaRoche.  \nReceived June 22, 2021; accepted June 25, 2021.  \nView this article online [at wileyonlinelibrary.com](at wileyonlinelibrary.com)  \nPublished 2021. This article is a U. S. Government work and is in the public domain in the USA.  \n1 | CliniCal liver Disease, vOl 18, nO 1, JUlY 2021 An Official Learning Resource of AASLD  \nreview ~~  HCV Elimination in the US Department of Vet~~erans~~ Affairs ~~Gonzalez et al.  \nHepatitis C Trends in VA, FY 2000-2020  \nFIG 1 Number of Veterans in care at VA facilities (yellow line), the number of Veterans awaiting HCV treatment (red line), and the number of Veterans ever treated for hepatitis C (green line), between fiscal year FY 2000 and FY 2020. Source: VA Hepatitis C Cube.  \nTaBle 1. COMPOnenTs anD FUnCTiOns OF THe va naTiOnal HePaTiTis C PrOGraM ([HTTPs://www](HTTPs://www). [HePaTiTis.va.GOv/HCv/inDeX.asP](HePaTiTis.va.GOv/HCv/inDeX.asP))  \nComponent Function  \nNational HCV Program Office National coordination and communication  \nHCV Clinical Case Registry (CCR) Local and national capture of clinical, laboratory, and pharmacy data on all HCV+ Veterans in VA care3  \nTesting/treatment guidelines Evidence-based standards for testing/treatment 4,5  \nHCV Lead Clinicians VAMC-level coordination and communication  \nHepatitis C Resou","cbCainH4WV37eUlm","https://ap.wps.com/l/cbCainH4WV37eUlm","pdf",448069,6,"English","# Hepatitis C Trends in VA, FY 2000-2020\n## National HCV Program Components and Functions\n## Hepatitis C Innovation Teams (HITs) and Implementation Approach","[{\"question\":\"What prompted the VA to launch a national HCV elimination program?\",\"answer\":\"The VA identified that HCV was more prevalent among Veterans in VA care than in the general US population, which triggered a comprehensive program focused on education, quality improvement, and clinical tool deployment.\"},{\"question\":\"What organizational infrastructure supported the VA’s rapid response in 2014?\",\"answer\":\"A robust HCV infrastructure, especially the national clinical case registry, enabled quick activation when all-oral direct-acting antivirals became available.\"},{\"question\":\"What was the role of Hepatitis C Innovation Teams (HITs)?\",\"answer\":\"HITs were small, field-based units designed to rapidly redesign clinical systems and drive innovations, using shared quantitative access and quality goals while selecting projects suited to each region.\"}]","HCV Elimination in the US Department of Veterans Affairs - Overview and Implementation Program | PDF",1789263661]